KANDERS WARREN B sold $2.1M of CDRE (indirect holdings)

KANDERS WARREN B (CEO AND CHAIRMAN) sold 75,000 indirectly-held shares of Cadre Holdings, Inc. (CDRE) at an average of $27.57 ($27.43–$27.86, $2.07M total) across 2 trades over 2026-06-18 to 2026-06-22.

Original reporting
SEC EDGAR · KANDERS WARREN B
Published Jun 23, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDRE
Neutral
medium confidence
Mentioned
$CDRE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDRENeutralLow
01

Why it matters

This provides a fresh, timestamped datapoint on insider behavior (CEO/Chairman indirect sale) that traders may incorporate into short-term sentiment, but it does not change operating outlook.

02

Market read

A $2.07M insider sale can slightly pressure sentiment, but there is no accompanying fundamental news in the filing text.

03

What to watch

The transactions are spread across two dates with a relatively tight price range; without context on total compensation, tax obligations, or prior sale patterns, the signal is weak.

Relevance 6/10Novelty 5/10Timing: after-hours/filing update on June 23 (SEC Form 4)

Background

The article is an SEC Form 4 insider transaction disclosure for Cadre Holdings, Inc. (CDRE).

Company-level read

Ticker impact

$CDRENeutralMedium confidence
Context

Cadre Holdings CEO/Chairman Kanders Warren B sold $2.07M of CDRE via indirect open-market transactions (75,000 shares) filed June 23.

Expected impact

Likely limited, short-lived sentiment impact unless follow-on selling accelerates or is paired with other negative disclosures.

Evidence & confidence

The filing is a routine insider sale (open-market, no 10b5-1 plan stated) with a defined window and value; it does not include new company fundamentals, guidance, or legal/operational developments.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale is not necessarily bearish—insiders often sell for diversification, taxes, or planned liquidity needs; absence of a stated 10b5-1 plan doesn’t automatically imply negative expectations.

Key entities

  • Cadre Holdings, Inc.

    Issuer of the Form 4 insider sale; ticker CDRE.

  • KANDERS WARREN B

    CEO and Chairman; reported indirect open-market sale of 75,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDREMed

Cadre Holdings Inc (CDRE) (Q3 2026) Earnings Call Highlights: 30% Sales Surge, Raised

Cadre Holdings (CDRE) reported a 30% sales surge in Q3 2026 and raised guidance. CFO Blaine Browers emphasized M&A as a priority, with a $100M buyback program. Tier's revenue is tracking at $120M, and the company completed a small bolt-on acquisition. President Brad Williams discussed AI initiatives and political impacts on consumer demand. Tier's international business is a key growth driver, with margin expansion expected.

$CDREMed

Cadre Holdings (CDRE) Q3 2026 Earnings Call Transcript

Cadre Holdings (CDRE) reported Q3 2026 earnings with net income up 46% and adjusted EBITDA margin at 20.2%. The company raised 2026 guidance and announced a $100M stock buyback program. It also completed an acquisition to vertically integrate capabilities. Management highlighted strong demand drivers in public and nuclear safety markets and a robust M&A pipeline. Net sales were $203M, and adjusted EBITDA was $41M, both exceeding expectations.

$CDREHigh

Cadre’s (NYSE:CDRE) Q3 2026: strong sales

Cadre reported Q3 2026 revenue of $202.9M, beating estimates by 6.4% and growing 30.2% YoY. EPS and EBITDA also exceeded expectations. The company raised full-year revenue guidance to $762.5M and EBITDA guidance to $142M. Operating margin improved to 14%, while free cash flow margin declined to 9.8%.